Sergey Petrovich Krechetov

Dr. Sergey Petrovich Krechetov

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
SSSergei V. Salihov
Sergei V. Salihov
YIYan A. Ivanenkov
Yan A. Ivanenkov
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
MVMark S. Veselov
Mark S. Veselov
NSNatalia V. Sviridenkova
Natalia V. Sviridenkova
AMAlexander G. Majouga
Alexander G. Majouga

2 June 2018 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
GNGalina Nifontova
Galina Nifontova
ODO. V. Dolotova
O. V. Dolotova
MVM. S. Veselov
M. S. Veselov

16 July 2018 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
GNGalina Nifontova
Galina Nifontova
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
ODO. V. Dolotova
O. V. Dolotova
SBS. R. Buyukli
S. R. Buyukli
AAA. R. Akhmetzyanova
A. R. Akhmetzyanova
IKI. I. Krasnyuk
I. I. Krasnyuk

17 August 2020 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
AMAnastasia Maksimovna Miroshkina
Anastasia Maksimovna Miroshkina
MYMaria Nikolaevna Yakovtseva
Maria Nikolaevna Yakovtseva
EMElizaveta Mochalova
Elizaveta Mochalova
ABAndrey Vadimovich Babenyshev
Andrey Vadimovich Babenyshev
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Purpose: Reducing the undesirable systemic effect of photodynamic therapy (PDT) can be achieved by incorporating a photosensitizer in microparticles (MPs). This study is devoted to the preparation of biocompatible biodegradable MPs with the inclusion of the natural photosensitizer Radachlorin (RС) and an assessment of the possibility of their use for PDT. Methods: RC-containing MPs (RС MPs) with poly(lactic-co-glycolic acid) copolymer (PLGA) matrix were prepared by a double emulsion solvent evaporation methods. The size and morphology of RC MPs were surveyed using scanning electron microscopy, confocal laser scanning microscopy, and dynamic light scattering. The content of RC, its release from RC MPs, and singlet oxygen generation were evaluated by the optical spectroscopy. Cellular uptake and cytotoxic photodynamic effect of RC MPs were investigated with in vitro assays. Results: The average diameter of the prepared RC MPs was about 2-3 μm. The RC MPsprepared by the water/oil/oil method had a significantly higher inclusion of RC (1.74 μg/mg) then RC MPs prepared by the water/oil/water method (0.089 μg/mg). Exposure of the prepared RC MPs to PDT light radiation was accompanied by the singlet oxygen generation and a cytotoxic effect for tumor cells. The release of the RC from the RC MPs was prolonged and lasted at least two weeks. Conclusion: PLGA RC MPs were found to cause a photoactivated cytotoxic effect for tumor cells and can be used for local application in PDT of tumors.

8 October 2021 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
MMM. S. Maslennikova
M. S. Maslennikova
NSN. L. Solovieva
N. L. Solovieva
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Introduction. Increasing of poorly soluble pharmaceutical substances bioavailability is one of important problems of pharmaceutical technology. Resveratrol is a plant origin polyphenol with a broad spectrum of biological effects. However, due to poor solubility and, as a result, low bioavailability, it is not promising for the development of oral drugs. Thus, today resveratrol is presented only as a biologically active substance that is component of biologically active food supplements.The objective of the research is selection of the optimal solubilizer to increase the solubility of resveratrol by determining the solubilization parameters.Materials and methods. The spectrophotometric characteristics of resveratrol were studied using three groups of solubilizers: poloxamers, polysorbates and cyclodextrins. Studies were carried out in 50 mM hydrochloric acid buffer(pH 1.2) and 50 mM phosphate buffer(pH 6.8). Spectrophotometric measurements were carried out on a spectrophotometer UV/VIS-3600 Shimadzu (Japan) in the wavelength range of 220–380 nm. The effect of solubilizers on the spectrophotometric characteristics of resveratrol was determined in buffer solutions containing the solubilizer and resveratrol in significantly less concentration of its own solubility in water. The used multiple excess of the solubilizer ensured the finding of all resveratrol in a solubilized form. During the determining parameters of solubilization, buffer solutions containing from 2 to 10 mM solubilizers were added to the obviously excess of resveratrol. The indicated amount of resveratrol ensured the presence of its precipitate in all experimentsto determine the completeness of solubilization of the studied polyphenol.Results. Based on the obtained spectrophotometric characteristics of solubilizers solutions with resveratrol, the most effective for the further development of solid dosage forms for oral administration are poloxamer 407, polysorbate 80 and modified methyl-beta-cyclodextrin, which ensure complete dissolution of resveratrol when its content in the composition with a solubilizer is about 10 %.Conclusion. Based on the data obtained on the spectrophotometric characteristics of resveratrol using solubilizers, it can be argued that it is possible to create drugs with improved solubility of the studied polyphenol. On the basis of its compositions with poloxamer 407, polysorbate 80 and modified methyl-beta-cyclodextrin, with the selection of appropriate excipients, solid dosage forms for oral intake can be developed.

15 July 2023 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
SKSergey Petrovich Krechetov
Sergey Petrovich Krechetov
MMM. S. Maslennikova
M. S. Maslennikova
AKA. Yu. Kuksin
A. Yu. Kuksin
AMAlexey Malinkin
Alexey Malinkin
NSN. L. Solovieva
N. L. Solovieva
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Background. The search for technology or the use of excipients for the development of drugs containing poorly soluble pharmaceutical substances is an urgent task of pharmacy. According to the biopharmaceutical classification system, resveratrol belongs to group 4: the substance has low solubility and low permeability. Therefore, one of the priorities in the development of drugs with resveratrol is to increase its solubility and, as a result, increase its permeability. The article presents the results of physicochemical studies of resveratrol compositions with solubilizers (poloxamer 407, polysorbate 80, methyl-beta-cyclodextrin) after dissolution in a common solvent followed by evaporation.Aim. Obtaining compositions of resveratrol with solubilizers and auxiliary formations with an exclusive study of their properties for the development of solid dosage forms.Materials and methods. Trans-resveratrol, poloxamer 407, polysorbate 80, methyl-beta-cyclodextrin, citric and ascorbic acids, glycerin, methanol; high performance liquid chromatography, differential scanning calorimetry.Results. Physical and chemical studies of the obtained compositions of resveratrol with excipients were carried out. Excipients used: citric and ascorbic acids for all compositions, as well as glycerin for compositions with tween 80. Stability studies were carried out under conditions of «accelerated aging», as a result of which a noticeable decrease in the amount of resveratrol was found (80 % of the original). Studies of the stability of resveratrol have shown that at low pH, inherent in the stomach, its content remains practically unchanged for two days. And at pH close to neutral, the content of resveratrol is reduced to 90 % of the original amount. The obtained results indicate the feasibility of developing drugs that promote the absorption of resveratrol in the stomach and are stored at low temperatures (in the refrigerator).Conclusion. Compositions of resveratrol with solubilizers were obtained and the choice of excipients for the development of solid dosage forms was substantiated. Recommendations are given for obtaining solid dosage forms for each of the developed formulations and storage conditions are determined.